Many patients with ME/CFS experience common herpesviruses infections at their disease onset. Alternatively, others experience reactivation of the same infections during the disease course. These facts suggest the existence of a disease-specific antibody signature related to these viruses. However, current evidence is conflicting about this signature due to the heterogeneous nature of the disease, the use of distinct lab assays, and small sample sizes, among other reasons.
In this webinar, Ramsay Grant researcher Nuno Sepúlveda, PhD, will present new findings on this signature, which could form the basis for developing a future diagnostic tool for ME/CFS patients with an infectious trigger.
Please send questions for Dr. Sepúlveda to email@example.com.
No one should suffer alone. Solve is helping millions of people with ME/CFS, Long Covid and other post-infection diseases. Join us today and your gift will be matched! All gifts made by November 30 will be matched up to $300,000! Help us make breakthroughs possible.